Meadow Creek Investment Management’s Agios Pharmaceuticals AGIO Stock Holding History

Meadow Creek Investment Management’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$37K	Buy	1,148 +784	+215%	+$32.5K	﹤0.01%	1280
2019 Q2	$18K	Sell	364 -5,124	-93%	-$274K	﹤0.01%	1328
2019 Q1	$370K	Buy	5,488 +1,624	+42%	+$94.6K	0.01%	802
2018 Q4	$178K	Buy	3,864 +3,668	+1,871%	+$226K	﹤0.01%	1003
2018 Q3	$15K	Sell	196 -364	-65%	-$29.3K	﹤0.01%	1303
2018 Q2	$47K	Buy	560 +504	+900%	+$44K	﹤0.01%	1259
2018 Q1	$5K	Buy	+56	New	+$4.33K	﹤0.01%	1319

Other funds holding AGIO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Meadow Creek Investment Management's AGIO Position: Q3 2019 in Review

Meadow Creek Investment Management increased its Agios Pharmaceuticals (AGIO) stake by 215% in Q3 2019, buying an estimated $32.5K and bringing the position to 1,148 shares worth $37K. The position accounts for ﹤0.01% of the portfolio, ranked #1280.

Meadow Creek Investment Management first reported a position in AGIO in Q1 2018 and has held it in 7 quarters since. The position peaked at $370K in Q1 2019. 189 funds tracked by Wall St. Rank hold AGIO as of Q3 2019.

Meadow Creek Investment Management held 1,148 shares of Agios Pharmaceuticals worth $37K as of Q3 2019.
Meadow Creek Investment Management bought 784 Agios Pharmaceuticals shares in Q3 2019, an estimated $32.5K.
Agios Pharmaceuticals made up ﹤0.01% of Meadow Creek Investment Management's portfolio in Q3 2019, its #1280 holding.
Meadow Creek Investment Management first reported a position in Agios Pharmaceuticals in Q1 2018 and has held it in 7 quarters since.
Meadow Creek Investment Management's Agios Pharmaceuticals position peaked at $370K in Q1 2019.
189 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2019.

Based on Meadow Creek Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.